Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C

This study has been completed.
Sponsor:
Information provided by:
Antipodean Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00433108
First received: February 7, 2007
Last updated: August 12, 2008
Last verified: August 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given
No publications provided by Antipodean Pharmaceuticals, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):